Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Conmed (CNMD) Short-Term Debt issuances (2016 - 2025)

Conmed (CNMD) has disclosed Short-Term Debt issuances for 12 consecutive years, with $187.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Short-Term Debt issuances rose 24.67% year-over-year to $187.0 million, compared with a TTM value of $695.4 million through Dec 2025, down 7.4%, and an annual FY2025 reading of $695.4 million, down 7.4% over the prior year.
  • Short-Term Debt issuances was $187.0 million for Q4 2025 at Conmed, up from $167.0 million in the prior quarter.
  • Across five years, Short-Term Debt issuances topped out at $254.0 million in Q1 2024 and bottomed at $62.0 million in Q2 2022.
  • Average Short-Term Debt issuances over 5 years is $146.3 million, with a median of $154.0 million recorded in 2023.
  • The sharpest move saw Short-Term Debt issuances surged 154.84% in 2023, then crashed 34.65% in 2025.
  • Year by year, Short-Term Debt issuances stood at $90.0 million in 2021, then soared by 58.89% to $143.0 million in 2022, then grew by 25.87% to $180.0 million in 2023, then decreased by 16.67% to $150.0 million in 2024, then increased by 24.67% to $187.0 million in 2025.
  • Business Quant data shows Short-Term Debt issuances for CNMD at $187.0 million in Q4 2025, $167.0 million in Q3 2025, and $175.4 million in Q2 2025.